GCTK

GlucoTrack Inc

NASDAQ: GCTK · HEALTHCARE · MEDICAL DEVICES

$1.82

-29.46% today

Updated 2026-09-25

Market cap

$2.04M

P/E ratio

0.15

P/S ratio

526.95x

EPS (TTM)

$17.25

Dividend yield

—

52W range

$2 – $136

Volume

12.0M

Market cap

$2.04M

P/E ratio

0.15

P/S ratio

526.95x

EPS (TTM)

$17.25

Dividend yield

—

52W range

$2 – $136

Volume

12.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.5

Quality

3.0

Profitability

6.7

Valuation

2/9

Piotroski F-Score

Weak

-34.5

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →260 stocks currently score above 75

Price targets

Analyst target

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Debt/equity -0.01x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -34.50 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-3.62M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-4.43M	$-7.10M	$-22.60M	$-19.39M	$-3.81M
EPS	—	—	—	—	$17.25
Free cash flow	$-3.73M	$-6.56M	$-12.59M	$-15.34M	$-3.62M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GCTK	$2.04M	27	4.3	3.0	6.7	4.5	—	Avoid
LLY	$1.03T	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$648.67B	59	4.7	8.5	3.7	5.5	—	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-73.51%	Strong Buy
MRK	$365.34B	36	4.0	4.5	2.0	5.0	-78.20%	Hold
UNH	$333.27B	62	7.3	5.5	5.3	5.5	-14.85%	Buy

Smart narrative

GlucoTrack Inc trades at $1.82. representing a P/E of 0.15x trailing earnings. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -34.50, it sits in the distress.

Frequently asked questions

What is GlucoTrack Inc's stock price?

GlucoTrack Inc (GCTK) trades at $1.82, on a P/E of 0.2x and a P/S of 527.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is GlucoTrack Inc overvalued?

GlucoTrack Inc carries a Smart Value Score of 27/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

GlucoTrack Inc's Altman Z-Score is -34.50, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

glucotrack.com

Quick metrics

P/S ratio526.95x

ROE-527.00%

Beta0.66

50D MA$5.43

200D MA$24.17

Shares out0.00B

Float0.00B

Short ratio—

Avg volume12.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

GCTK vs LLY →GCTK vs JNJ →GCTK vs ABBV →Stock screener →